These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34318959)

  • 1. In vivo evidence of differential frontal cortex metabolic abnormalities in progressive and relapsing-remitting multiple sclerosis.
    Swanberg KM; Prinsen H; DeStefano K; Bailey M; Kurada AV; Pitt D; Fulbright RK; Juchem C
    NMR Biomed; 2021 Nov; 34(11):e4590. PubMed ID: 34318959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
    Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosis.
    Vingara LK; Yu HJ; Wagshul ME; Serafin D; Christodoulou C; Pelczer I; Krupp LB; Maletić-Savatić M
    Neuroimage; 2013 Nov; 82():586-94. PubMed ID: 23751863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive performance in relapsing-remitting multiple sclerosis patients is associated with metabolic abnormalities of the thalamus but not the hippocampus- GABA-edited 1H MRS study.
    Kantorová E; Hnilicová P; Bogner W; Grendár M; Grossmann J; Kováčová S; Hečková E; Strasser B; Čierny D; Zeleňák K; Kurča E
    Neurol Res; 2022 Jan; 44(1):57-64. PubMed ID: 34313578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
    Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
    Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
    Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; McLean MA; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
    J Neurol; 2006 Feb; 253(2):224-30. PubMed ID: 16307201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy.
    Simister RJ; McLean MA; Barker GJ; Duncan JS
    Neurology; 2003 Oct; 61(7):897-902. PubMed ID: 14557556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.
    Tourbah A; Stievenart JL; Gout O; Fontaine B; Liblau R; Lubetzki C; Cabanis EA; Lyon-Caen O
    Neurology; 1999 Sep; 53(5):1091-7. PubMed ID: 10496272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    Schneider R; Bellenberg B; Hoepner R; Kolb EM; Ellrichmann G; Haghikia A; Gold R; Lukas C
    PLoS One; 2017; 12(4):e0176415. PubMed ID: 28445498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue.
    Kantorová E; Poláček H; Bittšanský M; Baranovičová E; Hnilicová P; Čierny D; Sivák Š; Nosáľ V; Zeleňák K; Kurča E
    Neurol Res; 2017 Apr; 39(4):323-330. PubMed ID: 28191860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of in vivo MRS measures of metabolite concentrations in the human brain.
    Dhamala E; Abdelkefi I; Nguyen M; Hennessy TJ; Nadeau H; Near J
    NMR Biomed; 2019 Mar; 32(3):e4058. PubMed ID: 30663818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.
    Brandt AS; Unschuld PG; Pradhan S; Lim IA; Churchill G; Harris AD; Hua J; Barker PB; Ross CA; van Zijl PC; Edden RA; Margolis RL
    Schizophr Res; 2016 Apr; 172(1-3):101-5. PubMed ID: 26925800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.
    Adalsteinsson E; Langer-Gould A; Homer RJ; Rao A; Sullivan EV; Lima CA; Pfefferbaum A; Atlas SW
    AJNR Am J Neuroradiol; 2003; 24(10):1941-5. PubMed ID: 14625214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging alters the multichemical networking profile of the human brain: an in vivo (1)H-MRS study of young versus middle-aged subjects.
    Grachev ID; Swarnkar A; Szeverenyi NM; Ramachandran TS; Apkarian AV
    J Neurochem; 2001 Apr; 77(1):292-303. PubMed ID: 11279285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T.
    Blicher JU; Eskildsen SF; Stærmose TG; Møller AT; Figlewski K; Near J
    Sci Rep; 2019 Nov; 9(1):17593. PubMed ID: 31772352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.
    Chard DT; Griffin CM; McLean MA; Kapeller P; Kapoor R; Thompson AJ; Miller DH
    Brain; 2002 Oct; 125(Pt 10):2342-52. PubMed ID: 12244090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis.
    Cao G; Edden RAE; Gao F; Li H; Gong T; Chen W; Liu X; Wang G; Zhao B
    Eur Radiol; 2018 Mar; 28(3):1140-1148. PubMed ID: 28986640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy.
    Castro-Fornieles J; Bargalló N; Lázaro L; Andrés S; Falcon C; Plana MT; Junqué C
    J Psychiatr Res; 2007 Dec; 41(11):952-8. PubMed ID: 17112540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal and thalamic changes of GABA concentration indicate dysfunction of thalamofrontal networks in juvenile myoclonic epilepsy.
    Hattingen E; Lückerath C; Pellikan S; Vronski D; Roth C; Knake S; Kieslich M; Pilatus U
    Epilepsia; 2014 Jul; 55(7):1030-7. PubMed ID: 24902613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.